BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 28450397)

  • 1. G protein-coupled estrogen receptor 1 (GPER1)/GPR30 increases ERK1/2 activity through PDZ motif-dependent and -independent mechanisms.
    Gonzalez de Valdivia E; Broselid S; Kahn R; Olde B; Leeb-Lundberg LMF
    J Biol Chem; 2017 Jun; 292(24):9932-9943. PubMed ID: 28450397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. G protein-coupled receptor 30 (GPR30) forms a plasma membrane complex with membrane-associated guanylate kinases (MAGUKs) and protein kinase A-anchoring protein 5 (AKAP5) that constitutively inhibits cAMP production.
    Broselid S; Berg KA; Chavera TA; Kahn R; Clarke WP; Olde B; Leeb-Lundberg LM
    J Biol Chem; 2014 Aug; 289(32):22117-27. PubMed ID: 24962572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G protein-coupled estrogen receptor (GPER)/GPR30 forms a complex with the β
    Tutzauer J; Serafin DS; Schmidt T; Olde B; Caron KM; Leeb-Lundberg LMF
    Arch Biochem Biophys; 2024 Feb; 752():109882. PubMed ID: 38211639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligand-Independent G Protein-Coupled Estrogen Receptor/G Protein-Coupled Receptor 30 Activity: Lack of Receptor-Dependent Effects of G-1 and 17
    Tutzauer J; Gonzalez de Valdivia E; Swärd K; Alexandrakis Eilard I; Broselid S; Kahn R; Olde B; Leeb-Lundberg LMF
    Mol Pharmacol; 2021 Sep; 100(3):271-282. PubMed ID: 34330822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hetero-oligomeric Complex between the G Protein-coupled Estrogen Receptor 1 and the Plasma Membrane Ca2+-ATPase 4b.
    Tran QK; VerMeer M; Burgard MA; Hassan AB; Giles J
    J Biol Chem; 2015 May; 290(21):13293-307. PubMed ID: 25847233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GPR30 activation opposes estrogen-dependent uterine growth via inhibition of stromal ERK1/2 and estrogen receptor alpha (ERα) phosphorylation signals.
    Gao F; Ma X; Ostmann AB; Das SK
    Endocrinology; 2011 Apr; 152(4):1434-47. PubMed ID: 21303939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF.
    Filardo EJ; Quinn JA; Bland KI; Frackelton AR
    Mol Endocrinol; 2000 Oct; 14(10):1649-60. PubMed ID: 11043579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dehydroepiandrosterone Activation of G-protein-coupled Estrogen Receptor Rapidly Stimulates MicroRNA-21 Transcription in Human Hepatocellular Carcinoma Cells.
    Teng Y; Radde BN; Litchfield LM; Ivanova MM; Prough RA; Clark BJ; Doll MA; Hein DW; Klinge CM
    J Biol Chem; 2015 Jun; 290(25):15799-15811. PubMed ID: 25969534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of GPR30 stimulates GTP-binding of Gαi1 protein to sustain activation of Erk1/2 in inhibition of prostate cancer cell growth and modulates metastatic properties.
    Lau KM; Ma FM; Xia JT; Chan QKY; Ng CF; To KF
    Exp Cell Res; 2017 Jan; 350(1):199-209. PubMed ID: 27908592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of GPR30 inhibits the growth of prostate cancer cells through sustained activation of Erk1/2, c-jun/c-fos-dependent upregulation of p21, and induction of G(2) cell-cycle arrest.
    Chan QK; Lam HM; Ng CF; Lee AY; Chan ES; Ng HK; Ho SM; Lau KM
    Cell Death Differ; 2010 Sep; 17(9):1511-23. PubMed ID: 20203690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of SAP97 protein in the regulation of corticotropin-releasing factor receptor 1 endocytosis and extracellular signal-regulated kinase 1/2 signaling.
    Dunn HA; Walther C; Godin CM; Hall RA; Ferguson SS
    J Biol Chem; 2013 May; 288(21):15023-34. PubMed ID: 23576434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Action of methyl-, propyl- and butylparaben on GPR30 gene and protein expression, cAMP levels and activation of ERK1/2 and PI3K/Akt signaling pathways in MCF-7 breast cancer cells and MCF-10A non-transformed breast epithelial cells.
    Wróbel AM; Gregoraszczuk EŁ
    Toxicol Lett; 2015 Oct; 238(2):110-6. PubMed ID: 26253279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropeptide Y receptor mediates activation of ERK1/2 via transactivation of the IGF receptor.
    Lecat S; Belemnaba L; Galzi JL; Bucher B
    Cell Signal; 2015 Jul; 27(7):1297-304. PubMed ID: 25817573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis.
    Filardo EJ; Quinn JA; Frackelton AR; Bland KI
    Mol Endocrinol; 2002 Jan; 16(1):70-84. PubMed ID: 11773440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human G protein-coupled receptor 30 is
    Gonzalez de Valdivia E; Sandén C; Kahn R; Olde B; Leeb-Lundberg LMF
    Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30760632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Betagamma subunits of G(i/o) suppress EGF-induced ERK5 phosphorylation, whereas ERK1/2 phosphorylation is enhanced.
    Obara Y; Okano Y; Ono S; Yamauchi A; Hoshino T; Kurose H; Nakahata N
    Cell Signal; 2008 Jul; 20(7):1275-83. PubMed ID: 18407464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-concentration BPF induced cell biological responses by the ERα and GPER1-mediated signaling pathways in MCF-7 breast cancer cells.
    Lei B; Huang Y; Liu Y; Xu J; Sun S; Zhang X; Xu G; Wu M; Yu Y; Feng C
    Ecotoxicol Environ Saf; 2018 Dec; 165():144-152. PubMed ID: 30195206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of EGF receptor transactivation in phosphoinositide 3-kinase-dependent activation of MAP kinase by GPCRs.
    Shah BH; Neithardt A; Chu DB; Shah FB; Catt KJ
    J Cell Physiol; 2006 Jan; 206(1):47-57. PubMed ID: 15920762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activated human hydroxy-carboxylic acid receptor-3 signals to MAP kinase cascades via the PLC-dependent PKC and MMP-mediated EGFR pathways.
    Zhou Q; Li G; Deng XY; He XB; Chen LJ; Wu C; Shi Y; Wu KP; Mei LJ; Lu JX; Zhou NM
    Br J Pharmacol; 2012 Jul; 166(6):1756-73. PubMed ID: 22289163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of activating ERK1/2 through G protein coupled receptor 30 and estrogen receptor α/β in low doses of bisphenol A promoting growth of Sertoli TM4 cells.
    Ge LC; Chen ZJ; Liu HY; Zhang KS; Liu H; Huang HB; Zhang G; Wong CK; Giesy JP; Du J; Wang HS
    Toxicol Lett; 2014 Apr; 226(1):81-9. PubMed ID: 24495410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.